Zosuquidar (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zosuquidar" in English language version.

refsWebsite

Global rank English rank

1^st place

1,182^nd place

725^th place

4^th place

1,684^th place

1,350^th place

2^nd place

5,225^th place

4,062^nd place

274^th place

309^th place

cancer.gov

"Zosuquidar trihydrochloride". NCI Drug Dictionary. National Cancer Institute. Archived from the original on 2023-02-10. Retrieved 2024-05-27.

Clinical trial number NCT00046930 for "Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia" at ClinicalTrials.gov

WO9424107 idem Jurg R. Pfister, Doris L. Slate, U.S. patent 5,654,304 (1997 to Syntex (U.S.A.) Inc.).
Bret Eugene Huff et al. U.S. patent 6,521,755 (2003 to Eli Lilly And Company).

"Zosuquidar - Kanisa Pharmaceuticals". Adis Insight. Springer Nature Switzerland AG. Archived from the original on 2023-02-10. Retrieved 2024-05-27.

"Zosuquidar trihydrochloride". NCI Drug Dictionary. National Cancer Institute. Archived from the original on 2023-02-10. Retrieved 2024-05-27.
"Zosuquidar - Kanisa Pharmaceuticals". Adis Insight. Springer Nature Switzerland AG. Archived from the original on 2023-02-10. Retrieved 2024-05-27.